Moneycontrol PRO
HomeNewsAurobindopharma

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Buy SBI, Hero Moto, Bajaj Auto, Maruti, Lupin: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com recommends buying SBI, Hero Moto, Bajaj Auto, Maruti Suzuki and Lupin.

  • 6 stocks likely to see lot of action today

    Rakesh Bansal of RK Global advises buying BEML with a target of Rs 1004.

  • Buy Dr Reddy's Labs, Aurobindo Pharma, M&M: Sudarshan Sukhani

    According to Sudarshan Sukhani of s2analytics.com, one can buy Dr Reddy's Laboratories, Aurobindo Pharma and Mahindra & Mahindra.

  • Buy Motherson Sumi, Voltas, Century Textiles: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Motherson Sumi Systems, Voltas and Century Textiles and Industries.

  • Buy Aurobindo Pharma, SBI, Himatsingka Seide: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy Aurobindo Pharma, State Bank of India and Himatsingka Seide.

  • Buy Aurobindo Pharma, Voltas, BPCL: Sandeep Wagle

    Sandeep Wagle of powermywealth.com recommends buying Aurobindo Pharma, Voltas and Bharat Petroleum Corporation.

  • Buy Pidilite Industries, Dr Reddy's Labs: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one can buy Pidilite Industries and Dr Reddy's Labs.

  • Tulsian on Ricoh India: Rush for exit, there is no hope

    In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his reading and outlook on the fundamental side of the market as well as on specific stocks and sectors.

  • Stock calls: Analysts to focus 5 largecap stocks today

    Bank of America Merill Lynch stays neutral on Wipro due to lack of triggers but thinks valuation will support. It has cut FY17-18 earnings per shat (EPS) by 4-5 percent and lowered target to Rs 540 per share.

  • Citi sees Sensex at 28,800; lists 5 largecaps, midcaps to buy

    Earnings upgrade cycle is key to sustaining valuations that otherwise look slightly stretched at 17-18 times forward earnings, says the Citi note

  • Houseviews: Analysts bet on 7 largecaps, 5 midcaps for profit

    Credit Suisse says GST is a major negative for alcohol companies as they are kept out of GST and earnings could get hit by 15-20 percent in FY18. It says input cost inflation could hit margin by 150-200 basis points. Input taxes on raw materials may become stranded with no offsets.

  • Hold Aurobindo Pharma, may touch Rs 900: Shahina Mukadam

    Shahina Mukadam, Independent Market Expert feels that Aurobindo Pharma may touch Rs 900.

  • Here are SP Tulsian's top trading ideas

    In an interview to CNBC-TV18's Anuj Singhal and Sonia Shenoy, SP Tulsian of sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks.

  • Buy PFC, Muthoot Finance, Aurobindo Pharma: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Power Finance Corporation, Muthoot Finance and Aurobindo Pharma.

  • Gautam Chhaochharia overweight on pharma space

    Gautam Chhaochharia, Head-India Research at UBS is overweight on pharma space.

  • Buy Aurobindo Pharma, United Spirits may test Rs 3200: Gujral

    Ashwani Gujral of ashwanigujral.com advises buying Aurobindo Pharma.

  • Buy Aurobindo Pharma, Pidilite; sell Bharat Forge: Ashish Kyal

    Ashish Kyal of wavesstrategy.com is of the view that one can buy Aurobindo Pharma and Pidilite Industries and sell Bharat Forge and Bharti Infratel.

  • Buy Pidilite, Oriental Bank; sell Union Bank: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy Pidilite Industries and Oriental Bank of Commerce and sell Union Bank of India.

  • Expect Aurobindo Pharma to test Rs 800, says Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com expects Aurobindo Pharma to test Rs 800.

  • No harm in subscribing to IT scrips despite gloom: SP Tulsian

    In an interview with CNBC-TV18, market expert, SP Tulsian gave his stock picks and told why he is bullish on pharma stocks for the month of July.

  • Super Six: Top chart picks for July 7

    Ashish Kyal of wavesstrategy.com suggests buying United Spirits with a target of Rs 2820.

  • Buy IndusInd Bank, Aban Offshore; sell Aurobindo Pharma: Gujral

    According to Ashwani Gujral of ashwanigujral.com, one can buy IndusInd Bank, Aban Offshore and Adani Ports and sell Aurobindo Pharma.

  • M&M, pharma stocks, Mahanagar Gas: See SP Tulsian's top picks

    In an interview with CNBC-TV18, market expert, SP Tulsian gave his stock picks for the day and talked about the listing of Mahanagar Gas on the Indian bourse.

  • Here are a few investment ideas from Rahul Arora

    In an interview to CNBC-TV18, Rahul Arora of Nirmal Bang Institutional Equities shared his readings and outlook on specific stocks and sector.

  • Here are a few investment ideas from Daljeet Singh Kohli

    In an interview to CNBC-TV18, Daljeet Singh Kohli of India Nivesh Securites shared his readings and outlook on specific stocks and sector.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347